Ted Monohon has served as Quince Therapeutics’ Chief Accounting Officer since February 2021 and Vice President of Finance since May 2019 and is currently the company’s Principle Financial Officer. Previously, Mr. Monohon served as a consultant to the company starting in December 2018.
Prior to joining Quince Therapeutics, Mr. Monohon served as Chief Financial Officer at X10 Capital, a private equity firm, from March 2017 to December 2018 and he served as Chief Financial Officer and Vice President of Finance at Fantex, Inc. from July 2012 to March 2017. Mr. Monohon holds a B.S. in Accounting from Rochester Institute of Technology.